STAT turns 10! 🎉

Join us in marking a decade of groundbreaking reporting at STAT.

Marking 10 years of STAT— read our story! Dear Readers, Today is an important milestone at STAT. We are 10 years old! When we named ourselves "STAT," we conceded that it might have seemed a little over the top. "It takes a bit of chutzpah to name a digital-age life-sciences publication after a buzzword born when leeches still roamed the apothecary," we wrote. "But we'll be honest: We're coming at this with no small amount of ambition." Little did we know what we were in for. The crush of news about health and medicine has been more relentless than we ever imagined. From our very first day, we were determined to deliver authoritative and deeply sourced journalism on subjects that require precision and meticulous reporting. So we hired the best of the best, from outlets including The New York Times, Reuters, Bloomberg, The Canadian Press, The Washington Post, and Politico, to name a few, as well as some dazzling young talent. Ten years — and nearly 40,000 stories and opinion essays — later, we are proud that our reporting has expanded the public understanding of the worlds of health and medicine, and made a difference.  Among our standout contributions: 2019 Secret Purdue Pharma files on its marketing of OxyContin unsealed after a nearly four-year legal fight waged by STAT. 2020 STAT was the first U.S. news organization to seize on the novel coronavirus as a potentially catastrophic global health threat, and consistently produced vital, prescient coverage of the Covid-19 pandemic. In March 2020, the New York Times described STAT as "the medical news site that saw the coronavirus coming months ago." 2022 Based on STAT's revelations about Biogen executives' use of a back channel to FDA officials to win approval of the Alzheimer's drug Aduhelm, a congressional investigation concludes that the approval was "rife with irregularities." 2023 Investigation of Epic's predictive model for sepsis helps inspire first federal disclosure requirements for AI tools embedded in hospital electronic health record systems.  2023 Medicare stepped up audits of insurers' refusal to cover patient care and issued new guidance on the use of AI tools to deny care, and two class-action lawsuits were filed in response to STAT's "Denied by AI" series, which revealed that insurers were using a computer algorithm to deny care to older and disabled patients. 2024 STAT's yearlong "Health Care's Colossus" investigation, which documented how UnitedHeath Group wields its market power to milk the health care system for profit, helped lead to two ongoing Justice Department investigations and spurred lawmakers' calls for reforms in the Medicare Advantage program. 2025 Virtually STAT's entire team of reporters has been covering how President Trump and his administration are transforming the federal government's health and science agenda, the implications of regulatory turns, the shockwaves from sweeping grant and job cuts, and the discussions behind closed doors in Washington and on Capitol Hill.  We're beginning our celebration today because on this date in 2015 we launched Morning Rounds, our flagship daily newsletter, followed quickly by the unveiling of our website, which — long before we knew he'd be the GOP presidential nominee — featured an investigation of a Donald Trump-branded vitamin business based on questionable science. We now have reporters across the country and one in Europe, a robust national events business, popular podcasts, a suite of newsletters, and deep-dive special reports. Our First Opinion section has become a platform for the most influential voices in health and medicine. Our STAT Wunderkinds, STAT Madness, and the STATUS List programs have played important roles in recognizing scientific discovery. We are humbled that we've won a broad range of prestigious journalism awards, and we've twice been named a Pulitzer Prize finalist.  At the same time, we are well aware that this has been a brutal decade for the media business, with many respected publications shuttering. Journalism is hard and is costly. We hope you can help us keep building a sustainable business that can allow us to pursue our ambitious growth strategy over the next 10 years. Please consider becoming a subscriber. To mark our anniversary, you can get your first 10 months of STAT+ for $10 a month. Subscribe now. Here's to the next 10 years! And, as always, I'm open for feedback at rick.berke@statnews.com. Sincerely, Rick Berke Co-Founder & Executive Editor, STAT ANNIVERSARY SALE Get 10 months of STAT+ for just $10/month SUBSCRIBE NOW More from STAT's 10-year anniversary STAT IMPACT Read 10 of the most impactful STAT stories of the past decade 2025 STAT Summit Hear from important voices on what could happen over the next 10 years in health and medicine STAT Mini Challenge yourself every week with STAT's new weekly mini crossword STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us